Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Randomized, placebo controlled study to determine if nebulized heparin may reduce the severity of lung injury caused by the novel coronavirus, also known as COVID-19
Epistemonikos ID: e3a1d9b98af01e60f9f0d87b44f479b83245474f
First added on: May 22, 2020